October 26, 2020

TFF Pharmaceuticals Expands its cGMP Manufacturing Capabilities with Experic

October 20, 2020

TFF Pharmaceuticals Updates Progress of Human Clinical Trial with Tacrolimus Inhalation Powder

September 30, 2020

TFF Pharmaceuticals Announces Results of Its 2020 Annual Meeting of Stockholders

September 24, 2020

TFF Pharmaceuticals Comments on Animal Studies in the Development of High Potency Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing

September 15, 2020

TFF Pharmaceuticals Announces Topline Results of Voriconazole Inhalation Powder Phase 1 Clinical Trial

September 14, 2020

TFF Pharmaceuticals to Participate in Anti-fungal Webinar Presented by Maxim Group LLC on September 17th, 2020

September 10, 2020

TFF Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

August 25, 2020

Fierce Pharma: Union, TFF team up to fight COVID-19 with inhaled tapeworm med

August 24, 2020

Outsourcing-Pharma.com: TFF, Union Therapeutics join on potential COVID-19 treatment

August 13, 2020

TFF Pharmaceuticals Reports Second Quarter 2020 Financial and Business Results